Switch to:
More From Other Websites
Lawsuit filed against former Mylan acquisition target Perrigo May 24 2016
5 Health Care Stocks John Paulson Is Betting On in 2016 May 24 2016
Stock Futures Edge Lower; Apple Reportedly Sets Strong IPhone Output May 23 2016
Hot New Solution For Diabetics May 23 2016
7:32 am Mylan Labs announces the U.S. launch of Doxycycline Hyclate Delayed-Release Tablets USP, 200... May 23 2016
Mylan Launches First Generic Doryx® Delayed-Release Tablets, 200 mg May 23 2016
J&J is Worth as Much as Gilead, Biogen, Mylan, Celgene and Teva Combined. It's Time to Sell. May 20 2016
Mylan Updates Timetable for Commencement of Acceptance Period for Offer for Meda May 17 2016
Term Sheet — Monday, May 16 May 16 2016
Mylan to Buy Renaissance's Topical Business for about $1B May 16 2016
David Tepper's Q1 Moves: Apple, Valeant And Much More May 13 2016
Mylan Tacks On Another Generics Company on the Cheap May 13 2016
Mylan To Buy Renaissance Acquisition Holdings' Generic And Specialty Business For $950 Million May 13 2016
Mylan to Buy Renaissance Skin Drug Unit for About $1 Billion May 13 2016
Mylan to Acquire Renaissance's Leading Topicals-Focused Specialty and Generics Business May 13 2016
Top Analyst Upgrades and Downgrades: Allergan, Lockheed Martin, Mylan, Nordstrom, Petrobras, NVIDIA,... May 13 2016
Stocks: Healthcare's More Than Just Biotech May 12 2016
Mylan Launches Generic Frova® Tablets May 12 2016
Allergan Plans $10B Share Repurchase: Is the Stock a Buy? May 10 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK